This translation has been automatically generated and has not been verified for accuracy.Justin Trudeau, second left, speaks with scientist Krishnaraj Tiwari, left, as Minister of Economic Development Mélanie Joly, centre, and Minister of Science and Industry Navdeep Bains look on during a visit to the National Research Council of Canada Royalmount Human Health Therapeutics Research Centre facility in Montreal, on Aug 31, 2020.Ottawa has struck new deals with two additional U.S.
“Our strategy is to secure agreements with numerous developers of vaccine candidates so that Canadians are well positioned as clinical trials advance among these developers,” Anita Anand, Minister of Public Services and Procurement, said in a press conference. “Diversification in our vaccine contracts and in our supply is crucial.”it had reached agreements with Moderna Inc. and Pfizer Inc. to acquire their potential vaccines. Releasing further details of those contracts, Ms.
Countries around the world are currently jockeying to reserve doses from various producers as soon as their vaccines become available. Ms. Anand hinted at the fierce competition involved in these negotiations. Steven Hoffman, a professor of global health, law and political science at York University, said that he would have preferred to see Canada and other well-off countries work exclusively through a World Health Organization-led effort to collectively develop and distribute COVID-19 vaccines for the globe.
Good for our govt but what will these deals be worth if Prez Trump is re-elected?